These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15386815)

  • 21. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study.
    Pajunen P; Peltonen M; Eriksson JG; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J; Lindström J;
    Diabet Med; 2011 Jan; 28(1):36-42. PubMed ID: 21166843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.
    Colagiuri S; Hussain Z; Zimmet P; Cameron A; Shaw J;
    Diabetes Care; 2004 Feb; 27(2):367-71. PubMed ID: 14747215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of HbA(1c) in screening for Cuban-Americans with undiagnosed type 2 diabetes.
    Huffman FG; Exebio JC; Zarini GG; Exebio C
    J Immigr Minor Health; 2011 Jun; 13(3):541-5. PubMed ID: 20577810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark.
    Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Diabetologia; 2010 Nov; 53(11):2328-33. PubMed ID: 20697688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
    Bennett CM; Guo M; Dharmage SC
    Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in an acute-care setting.
    Silverman RA; Thakker U; Ellman T; Wong I; Smith K; Ito K; Graff K
    Diabetes Care; 2011 Sep; 34(9):1908-12. PubMed ID: 21775751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey.
    Bao Y; Ma X; Li H; Zhou M; Hu C; Wu H; Tang J; Hou X; Xiang K; Jia W
    BMJ; 2010 May; 340():c2249. PubMed ID: 20478961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between glycated hemoglobin and glucose concentrations in the adult Galician population: selection of optimal glycated hemoglobin cut-off points as a diagnostic tool of diabetes mellitus.
    Botana López MA; López Ratón M; Tomé MA; Fernández Mariño A; Mato Mato JA; Rego Iraeta A; Pérez Fernández R; Cadarso Suárez C
    Endocrinol Nutr; 2012 Oct; 59(8):496-504. PubMed ID: 22857908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
    Inoue K; Matsumoto M; Akimoto K
    Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
    Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
    Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults.
    Sung KC; Rhee EJ
    Diabet Med; 2007 Aug; 24(8):848-54. PubMed ID: 17650158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
    Sundborn G; Metcalf P; Scragg R; Schaaf D; Dyall L; Gentles D; Black P; Jackson R
    N Z Med J; 2007 Jun; 120(1257):U2607. PubMed ID: 17632597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HbA(1c) measurement for the diagnosis of diabetes: is it enough?
    Cavagnolli G; Comerlato J; Comerlato C; Renz PB; Gross JL; Camargo JL
    Diabet Med; 2011 Jan; 28(1):31-5. PubMed ID: 21210540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark.
    Lauritzen T; Sandbaek A; Skriver MV; Borch-Johnsen K
    Diabetologia; 2011 Jun; 54(6):1318-26. PubMed ID: 21340624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
    Borg R; Vistisen D; Witte DR; Borch-Johnsen K
    Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.
    Shand B; Scott R; Connolly S; Clarke R; Baker J; Elder P; Frampton C; Yeo J
    Diabetes Obes Metab; 2007 Jul; 9(4):540-7. PubMed ID: 17587396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The glucose tolerance test, but not HbA(1c), remains the gold standard in identifying unrecognized diabetes mellitus and impaired glucose tolerance in hypertensive subjects.
    Salmasi AM; Dancy M
    Angiology; 2005; 56(5):571-9. PubMed ID: 16193196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.